Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

Literature Scan

New and noteworthy research from the medical literature landscape
Phase IIIb Results Show Avatrombopag to Be Safe, Effective Treatment for Children With ITP Free
Lara C. Pullen, PhD
August 29, 2025
IMS-IMWG Releases New Consensus Definition of High-Risk MM Based on Genomics Free
Katie Robinson
August 29, 2025
Cyclosporin-Cyclophosphamide Performs Well for GVHD Prevention After Transplant Free
Thomas R. Collins
August 29, 2025
Reconceptualizing High ED Use in Patients With SCD Free
Ruth Jessen Hickman, MD
August 13, 2025
Individualized Therapy Associated With Greater Rates of Undetectable MRD, Extended PFS in CLL Free
Khylia Marshall
August 13, 2025
Subcutaneous Isatuximab Noninferior to IV Administration in R/R MM Free
Tess Stafford
August 13, 2025
Long-Term Data Confirm Early Rituximab Monotherapy Delays New Treatment in Advanced, Asymptomatic LTBFL Free
Katie Robinson
July 31, 2025
Exploring Heterozygote Bleeding Risk in Rare Bleeding Disorders Free
Ruth Jessen Hickman, MD
July 31, 2025
Cytokine-Secreting CAR T-Cell Candidate Therapy Shows Preliminary Efficacy in Patients With Lymphoma Free
Anna Azvolinsky, PhD
July 31, 2025
Study Validates Revised FLC Reference Intervals, Improving Prognostic Accuracy in MGUS Free
Khylia Marshall
July 31, 2025
Iron Deficiency Potentially Underdiagnosed in Females With Bleeding Disorders Free
Ruth Jessen Hickman, MD
July 16, 2025
Critical Limb Ischemia Outcomes Worse Among Those With MPNs Free
Leah Lawrence
June 16, 2025
Real-World Venetoclax Combinations for MM Show Evidence of Efficacy in Patients Harboring t(11;14) Free
Thomas R. Collins
June 16, 2025
Quadruplet Therapy Safe, Effective for Some Frail Patients with NDMM Free
Leah Lawrence
June 10, 2025
Cilta-Cel Shows Superior Efficacy, Survival Over Ide-Cel, but Higher Toxicity in R/R MM Free
Katie Robinson
May 28, 2025
24-Hour Urine-Based Response Test Not Necessary for MM Free
Leah Lawrence
May 28, 2025
Large Study Clarifies Risk of Thrombosis Associated With Protein S Deficiency Free
Anna Azvolinsky, PhD
May 22, 2025
Analysis Offers Insight Into CAR-T-Related Secondary Malignancies Free
Thomas R. Collins
May 22, 2025
Combination Pelabresib-Ruxolitinib Shows Disease Burden Benefit in Patients With Myelofibrosis Free
Khylia Marshall
May 22, 2025
Daratumumab-Containing Quadruplet Effective as First-Line in Transplant-Ineligible NDMM, Randomized Trial Finds Free
Thomas R. Collins
May 1, 2025

Advertisement intended for health care professionals

Connect with us:

CURRENT ISSUE
September 2025

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals